Since Ki-67 and cytokeratin testing are not commonly reported in many countries, the breast cancer subtypes are typically classified based on the presence of estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor-2 (HER-2). Here, ERBB2 is linked to breast carcinoma.